Johnson & Johnson starts rolling review for COVID-19 vaccine in Europe
Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.
Archives for December 1, 2020
An experimental gene therapy may be effective for MND patients with a newly discovered genetic mutation
A neuroprotective drug which is already in development may be particularly effective for MND patients carrying a newly discovered genetic risk factor, helping to halt progression or even prevent the onset of the devastating degenerative disease.
Pfizer and Moderna apply for European COVID-19 vaccine authorization
Pfizer/BioNTech and Moderna have each submitted formal applications for Conditional Marketing Authorization (CMA) to the European Medicines Agency (EMA) for their COVID-19 vaccines: completing the rolling review process.
Researchers make ‘exciting first step’ to better understanding development and treatment of autism
US based scientists have hit upon a method to efficiently identify potential biological mechanisms underlying autism spectrum disorder (ASD); the Harvard and MIT based researchers say the approach is an important first step toward developing treatments...